Evidence map›Paper›PMID 30125425›Full record

ArticleProtein science : a publication of the Protein Society2018

Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior.

Gaurav Ghag, Nemil Bhatt, Daniel V Cantu, Marcos J Guerrero-Munoz, Anna Ellsworth, Urmi Sengupta, Rakez Kayed

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 151 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Nuclear dysfunction in aging and neurodegeneration.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  5. Article
  6. Mitochondrial NADK2-dependent NADPH controls tau oligomer uptake in human neurons.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. APOE isoform-associated tau oligomer polymorphs differ in synaptotoxicity and seeding activity.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. A brain-derived tau oligomer polymorph is associated with cognitive resilience to Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gaurav GhagMitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas 77555.
Nemil BhattMitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas 77555.
Daniel V CantuMitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas 77555.
Marcos J Guerrero-MunozMitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas 77555.
Anna EllsworthMitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas 77555.
Urmi SenguptaMitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas 77555.
Rakez KayedMitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas 77555.
The University of Texas Medical Branch at Galveston · US

Funding

Formation and Propagation of Tau Oligomeric Strains in Alzheimer's DiseaseR01AG054025 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Rakez Kayed · 2016 to 2026
$5.8M
Intersection of alpha synuclein and tau contributions to neurotoxicityR01NS094557 · NINDS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI DINELEY, KELLY T, KAYED, RAKEZ · 2016 to 2020
$2.8M
Tau in the Eye and BrainRF1AG055771 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI KAYED, RAKEZ, ZHANG, WENBO · 2017 to 2017
$2.7M
NIA NIH HHS R01 AG054025NIA NIH HHS RF1 AG055771NINDS NIH HHS R01 NS094557
6 · The paper itself

Abstract

Several studies have proposed that fibrillary aggregates of tau and other amyloidogenic proteins are neurotoxic and result in numerous neurodegenerative diseases. However, these studies usually involve sonication or extrusion through needles before experimentation. As a consequence, these methods may fragment large aggregates producing a mixture of aggregated species rather than intact fibrils. Therefore, the results of these experiments may be reflective of other amyloidogenic species, such as oligomers and/or protofibrils/short fibrils. To investigate the effects of sonication on the aggregation of tau and other amyloidogenic proteins, fibrils were prepared and well characterized, then sonicated and evaluated by various biochemical and biophysical methods to identify the aggregated species present. We found that indeed a mixture of aggregated species was present along with short fibrils indicating that sonication leads to impure fibril samples and should be analyzed with caution. Our results corroborate the previous studies showing that sonication of prion and Aβ fibrils leads to the formation of toxic, soluble aggregates. We also show that the oligomeric forms are the most toxic species although it is unclear how sonication causes oligomer formation. Recent results suggest that these small toxic oligomers produced by sonication, rather than the stable fibrillar structures, are prion-like in nature displaying seeding and cross-seeding behavior.

Indexed as

Protein MultimerizationAmyloid beta-PeptidesAmyloidogenic ProteinsAntibodiesCell LineCell SurvivalCross-Linking ReagentsEscherichia coliHistocompatibility Antigens Class IHumansPrionsProtein ConformationSonicationtau ProteinsAmyloid beta-PeptidesAmyloidogenic ProteinsAntibodiesCross-Linking ReagentsHistocompatibility Antigens Class IPrionsT22 antigentau Proteinsamyloidsonicationtau oligomerstauopathies

Identifiers

PMID30125425
PMCPMC6201727
OpenAlexW2888700770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.